3 New Strong Buy Ratings from Top-Rated Analysts: 09/30/2026
Looking for some fresh picks? Get on board with these:
- CareDx (CDNA): 83% profit margin and #1 in diagnostics
- International Seaways (INSW): Tanker rates surging on oil supply disruptions
- Micron Technology (MU): Ten top-1% analysts back this AI memory play
P.S. Get more alerts like this daily … Try WallStreetZen Premium.
A note from our sponsors...
The ONLY AI opportunity you should be looking at
This is the ONLY AI wealth-building opportunity you should be watching right now.
No. It's not about Nvidia, Tesla, or Meta...
It's about one overlooked company profiting off AI "digital goldmines" that are poised to experience 100x growth very soon.
This new opportunity will change the market and make investors a lot of money.
That's why it has received a $500 billion commitment from President Trump himself...
Learn more about this little-known company here >>>
1. CareDx (NASDAQ: CDNA)
This company provides a toolkit for transplant recipients and healthcare providers. More interestingly from an investment perspective, they have posted remarkable profitability with an 83.8% profit margin, and recent Medicare lab fee changes are expected to impact the transplant diagnostics landscape favorably.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $64.68 — get current quote
Max 1-year forecast: $74.00
Why we're watching:
- CDNA has limited, but overall bullish, coverage among the analysts we track, with 2 Strong Buy and 1 Hold recommendations. See all recommendations here
- For example, BTIG researcher Mark Massaro (a top 2% rated analyst) recently maintained his Strong Buy recommendation with a price target suggesting nearly 20% upside potential from current levels, following investor meetings where management expressed confidence in the resolved transplant LCD and excitement about the Naveris acquisition.
- Industry ranking context: CDNA is currently the #1 highest-rated stock in the Diagnostic & Research industry, which has an Industry Rating of B.
- Zen Ratings highlights: CDNA earns an overall A rating, which amounts to a Strong Buy recommendation. This tier represents the top 5% of all stocks tracked, passing a rigorous 115-factor fundamental review.
- Component Grades: CDNA stands out with As for Financials and Momentum, paired with solid Bs for Growth and Sentiment. This reflects the company's exceptional profitability and strong market positioning in the transplant diagnostics space. See all 7 Component Grades here
2. International Seaways (NYSE: INSW)
This energy enabler owns and operates a fleet of 83 oceangoing vessels that transport crude oil and petroleum products globally. Right now, the company is capitalizing on oil supply disruptions and customers increasingly securing long-term tanker capacity, driving strong rates and profitability with a 63.1% profit margin.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $108.31 — get current quote
Max 1-year forecast: $130.00
Why we're watching:
- INSW has limited, but overall bullish, coverage among the analysts we track, with 2 Strong Buy recommendations. See all recommendations here
- For example, BTIG researcher Gregory Lewis (a top 3% rated analyst) recently maintained his Strong Buy recommendation and a price target suggesting the stock could see greater than 20% upside potential from current levels, noting that oil supply disruptions continue to support rates as customers increasingly go long tanker tonnage.
- Industry ranking context: INSW is currently the #4 highest-rated stock in the Oil & Gas Midstream industry, which has an Industry Rating of A.
- Zen Ratings highlights: INSW earns an overall A rating, which is equal to a Strong Buy recommendation. Stocks with this rating represent the elite top 5% of all stocks tracked based on a careful 115-factor fundamental analysis.
- Component Grades: INSW excels with As for Financials and Momentum, while maintaining a strong B for Value. This combination reflects the company's exceptional profitability and its ability to capitalize on favorable tanker market dynamics. See all 7 Component Grades here
3. Micron Technology (NASDAQ: MU)
This Master of the Memory Universe company has achieved an impressive 68.1% profit margin while establishing itself as a cornerstone player in AI infrastructure, with analysts projecting it could become the biggest driver of S&P 500 profit growth.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $1,055.37 — get current quote
Max 1-year forecast: $2,000.00
Why we're watching:
- MU has exceptionally strong, bullish coverage among the analysts we track, with 16 Strong Buy, 6 Buy, and 1 Hold recommendations. See all recommendations here
- For example, Wells Fargo researcher Aaron Rakers (a top 1% rated analyst) maintained his Strong Buy recommendation with a price target suggesting nearly 30% upside potential.
- Even better, Rosenblatt researcher Kevin Cassidy (also a top 1% rated analyst) recently maintained his Strong Buy recommendation with a price target roughly 40% above current levels.
- Industry ranking context: MU is currently the #2 highest-rated stock in the Semiconductor industry, which has an Industry Rating of A.
- Zen Ratings highlights: MU earns an overall A rating, which amounts to a Strong Buy recommendation. Stocks in this topmost tier have historically delivered nearly 30% annual returns, soundly beating the S&P.
- Component Grades: MU stands out with exceptional As for Financials, Growth, and Momentum, paired with a solid B for Value. This reflects the company's extraordinary profitability and its central role in powering the AI revolution through advanced memory solutions. See all 7 Component Grades here
What to Do Next?
Want to get in touch? Email us at news@wallstreetzen.com.
Keep Reading
See All News
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.